Jane Street’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,837
Closed -$96.4K 6959
2024
Q3
$96.4K Buy
+25,837
New +$96.4K ﹤0.01% 5484
2024
Q1
Sell
-23,626
Closed -$124K 6464
2023
Q4
$124K Buy
+23,626
New +$124K ﹤0.01% 5199
2023
Q3
Sell
-47,693
Closed -$927K 5866
2023
Q2
$927K Sell
47,693
-17,184
-26% -$334K ﹤0.01% 3123
2023
Q1
$1.84M Buy
64,877
+43,430
+202% +$1.23M ﹤0.01% 2141
2022
Q4
$627K Buy
+21,447
New +$627K ﹤0.01% 3141
2022
Q3
Sell
-12,620
Closed -$561K 6499
2022
Q2
$561K Buy
12,620
+3,278
+35% +$146K ﹤0.01% 3424
2022
Q1
$462K Buy
9,342
+1,655
+22% +$81.8K ﹤0.01% 3850
2021
Q4
$391K Buy
7,687
+2,399
+45% +$122K ﹤0.01% 3733
2021
Q3
$295K Buy
+5,288
New +$295K ﹤0.01% 3995
2021
Q1
Sell
-7,900
Closed -$368K 5481
2020
Q4
$368K Sell
7,900
-1,214
-13% -$56.6K ﹤0.01% 2989
2020
Q3
$387K Buy
+9,114
New +$387K ﹤0.01% 2663
2018
Q2
Sell
-4,021
Closed -$212K 3847
2018
Q1
$212K Buy
+4,021
New +$212K ﹤0.01% 2780
2017
Q3
Sell
-3,073
Closed -$242K 3465
2017
Q2
$242K Buy
3,073
+420
+16% +$33.1K ﹤0.01% 2453
2017
Q1
$220K Buy
+2,653
New +$220K ﹤0.01% 2470
2016
Q3
Hold
0
3139
2016
Q2
Sell
-5,112
Closed -$207K 3050
2016
Q1
$207K Buy
+5,112
New +$207K ﹤0.01% 2266
2015
Q4
Sell
-6,699
Closed -$496K 3114
2015
Q3
$496K Buy
6,699
+1,372
+26% +$102K ﹤0.01% 1577
2015
Q2
$431K Sell
5,327
-2,798
-34% -$226K ﹤0.01% 1645
2015
Q1
$340K Buy
+8,125
New +$340K ﹤0.01% 1670